Pacific Edge serves up harsh dessert for shareholders
The vexed issue of shareholder compensation for continuous disclosure violations has reared its head again, prompting plenty of discussion in the market.
Shoeshine Fri, 29 May 2015
The vexed issue of shareholder compensation for continuous disclosure violations has reared its head again, prompting plenty of discussion in the market.
The latest case, involving Dunedin-based biotech company Pacific Edge [NZX: PEB], will have sent a jolt through the market, with many listed
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).